Donna Lee Yesner represents clients in transactions, disputes, regulatory compliance, and strategic business planning relating to public healthcare programs and government contracts. Frequently representing clients in the pharmaceutical, biological, and medical device industries, Donna advises on US Federal Supply Schedule contracting, pharmaceutical research and development agreements, and matters involving suspension, debarment, and exclusion from federal programs. She also counsels companies on federal healthcare program reimbursement, drug price reporting, and compliance requirements, and their potential business impact on the companies.
Donna advises clients on issues involving the acquisition and reimbursement of US federal healthcare supplies and services, particularly contracts involving the US Department of Veterans Affairs (VA), the US Department of Defense (DOD), and the US Department of Health and Human Services (HHS). She also counsels on compliance issues relating to Medicaid, Medicare, Tricare, and the 340B drug discount programs; debarment and public policy affecting these programs; and healthcare fraud.
Additionally, Donna has represented clients in litigation and alternative dispute resolution matters before US District Courts and Courts of Appeals, boards of contract appeals, and before the US Court of Federal Claims.
Articles in the National Law Review database by Donna Lee Yesner